Angelini Farmacéutica (Spain)

Angelini started operating in Spain in 1978 through the acquisition of the laboratory Farma Lepori, which already had a long experience in the Spanish pharmaceutical sector both in the production and in the distribution. In July 2008, Farma Lepori changed its name to Angelini Farmacéutica.

Angelini Spain headquarter is located in Barcelona.

The main therapeutic areas of Angelini Farmacéutica in the ethical division are orthopedics, rheumatology, pain, ophthalmology, infectious diseases, central nervous system, gynaecology, fertility and women health.

In the orthopedics and rheumatology business area, Angelini is the first one in terms of turnover being leaders in the area of chondroprotection with Condrosulf, an osteoarthritis symptomatic treatment.

In the pain area, Angelini is recently present with Avaric, fentanyl citrate sublingual tablets indicated for the treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy.

In the ophthalmology field, Angelini’s product portfolio includes AREDSan, a food supplement with a specific formula (omega 3 fatty acids, lutein and zeaxanthin, vitamins and minerals) based in the AREDS and AREDS2 studies. The AREDSan product range helps protect the eye health. Lubristil is another of the main products in the ophthalmology portfolio: artificial tears with hyaluronic acid indicated for the treatment of the dry eye disease.

In the neuropsychiatric field, Angelini is on the market with Deprax (Trazodone), an anti-depressive, developed by Angelini worldwide in the early 60’s.

In the infectious disease field, Angelini has recently launched Xydalba (dalbavancin). Dalbavancin is the first and only IV antibiotic approved for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI), with a single dose regimen of 1500 mg administered over 30 minutes.

In the field fertility, Angelini is present with Fostipur and Meriofert Kit, controlled ovarian hyper stimulators to induce the development of multiple follicles,

In the women’s health area, Angelini Farmacéutica is present with Rosalgin (benzydamine), a vulvovaginal anti-inflammatory product. Angelini leads in the probiotics and breastfeeding field with Lactanza Hereditum. It is first available probiotic (Lactobacillus fermentum Lc40) in market isolated from breastmilk able to restore the equilibrium in the mammary flora of women during breastfeeding.

Consumer Healthcare is one of the strategic areas for Angelini Spain. The main brands of Angelini Farmacéutica in this business area are: Juanola, with a range of products for the respiratory tract area (cough&cold, sore throat, descongestants...), Tantum Verde (benzydamine), an anti-inflammatory for the throat, Valeriana Leo, to favor relaxation and to treat sleep disorders, and the polyvitaminic Leotron.

 

MAIN BRANDS THERAPEUTIC AREA
Condrosulf Orthopedics/Rheumatology
Avaric Cancer Pain
Aredsan - Lubristil Ophtalmology
Deprax CNS
Fostipur - Meriofert Kit Fertility
Rosalgin - Lactanza - Gravidanza Gynaecology
Xydalba Infectious Diseases
Tantum Verde Sore throat treatment
Juanola Throat and respiratory tract

The Juanola pastilles, marketed in Spain since 1906, have become one of the better known, top-selling and most appreciated products in the OTC market. The pastilles are characterized by natural ingredients and by an original formula, which has been passed down from generation to generation and has remained virtually unchanged for a century.
In order to adapt to the increasingly demanding markets, in 2014 Juanola’s plant obtained ISO 9001 and ISO 22000 certifications.

Angelini Spain employs 207 people, of which 147 are sales representatives spread all over the country.
According to IMS, in the OTC market Angelini Spain occupies the 10th position, and the 62nd position in the prescription market (IMS Health Values MAT July 2015).
All Angelini's activities in Spain, both in the consumer healthcare and in the ethical division, produce a turnover of 73,5M€ (2016).